$OGI

Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026

Organigram Global Inc. (NASDAQ: OGI, TSX: OGI) said it will release third-quarter fiscal 2026 results for the quarter ended June 30, 2026 on Aug. 11, 2026 before market open. The company will hold a conference call at 8:00 a.m. ET, with a webcast and replay available on its investor site.

Original reporting
Published Aug 4, 2026, 10:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 10:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026 — source image
Decision brief

The 30-second read

$OGINeutralMed
01

Why it matters

The key tradable element is event timing. The release date and call schedule can drive pre-earnings positioning, options implied volatility, and intraday volatility around the Aug 11 print, but the article contains no earnings numbers or guidance.

02

Market read

This is a routine earnings calendar update that primarily matters for managing event risk into the Aug 11 pre-market release.

03

What to watch

Traders should focus on what management may emphasize in the call (e.g., Germany medical cannabis progress post-Sanity acquisition), but those details are not provided here.

Relevance 5/10Novelty 5/10Timing: ahead of Aug 11, 2026 pre-market earnings release

Background

Organigram Global Inc. announced it will report third quarter fiscal 2026 results for the period ended June 30, 2026 on Tuesday, Aug 11, 2026, prior to market open, and will host a conference call at 8:00am ET.

Company-level read

Ticker impact

$OGINeutralMedium confidence
Context

Organigram (OGI) scheduled its Q3 fiscal 2026 results for Aug 11, 2026, prior to market open, with a 8:00am ET call.

Expected impact

Likely modest pre-event positioning and higher implied volatility into Aug 11; direction depends on the forthcoming results and guidance.

Evidence & confidence

The article discloses no financial figures or guidance, only the reporting date, call time, and replay availability, which mainly affects timing and event-risk pricing.

Market effects

Adds another scheduled earnings catalyst for the Canadian and European cannabis complex, but provides no new sector datapoint.

Primarily impacts North American cannabis sentiment around the Aug 11 earnings window.

Limited global spillover since the release is company-specific and contains no new international regulatory or demand information.

Counterpoint

Because this is only an earnings date announcement, the market may already price the event, reducing incremental trading edge versus waiting for the actual results.

Key entities

  • Organigram Global Inc.

    NASDAQ: OGI, TSX: OGI. Scheduled Q3 fiscal 2026 results for Aug 11, 2026 and a conference call at 8:00am ET.

Related articles

$OGIMedAI 9/10

Organigram Global Inc (OGI) Raises 2026 Guidance on Sanity Acquisition

Organigram Global Inc (NASDAQ:OGI) reported March-quarter results on May 12. Net revenue fell 9% YoY to $59.8M and adjusted EBITDA was $0.9M versus $4.9M a year earlier, citing weakness in vapes, pre-roll production issues, and slower industry growth. The company raised 2026 revenue guidance to $350M from $300M, expecting Sanity Group (acquired end of March) to add about €25M quarterly revenue.

$UMACMed

Unusual Machines Q2 Earnings Call Highlights

Unusual Machines (UMAC) said it grew staff to 240 as of July 1 and ended Q2 with $229 million cash, including $60 million raised via ATM in May at $30/share, plus $86 million short-term investments and $42.4 million inventory. Management reported no debt, working capital over $367 million, and internal revenue targets of $12-$14 million in Q3 and $25 million in Q4, while citing scaling issues and plans to acquire Upgrade Energy.

$STRWMed

Strawberry Fields REIT Q2 Earnings Call Highlights

Strawberry Fields REIT (STRW) reported Q2 adjusted funds from operations (AFFO) of $73.9 million and projected 10.1% AFFO-per-share growth. It posted adjusted EBITDA of $135.7 million, 14.4% lease yield, and net debt to net assets of 49.8%. The board approved a $0.17 quarterly dividend. The company closed a $300 million credit facility and contracted to buy a Missouri hospital campus for $10.4 million.

$PYYXMed

Pyxus International Q1 Earnings Call Highlights

Pyxus International reported Q1 cost and cash-flow updates on its earnings call. Adjusted EBITDA fell to $27.7M from $29.5M, but rose on a rolling 12-month basis to $225M. Adjusted free cash flow improved to $123.4M (12-month). Cash was $175.9M with no ABL borrowings; leverage improved to 4.9x. Management discussed debt maturity resolution and expected stronger shipments.

$GROYMed

Gold Royalty Q2 Earnings Call Highlights

Gold Royalty Corp (GROY) discussed its Q2 earnings call, saying its NSR royalty model is based on revenue and can be insulated from mine operating cost inflation. It maintained 2026 guidance of 7,500 to 9,300 GEOs, with 1H at 44% of the midpoint. It also outlined ramp-up and acquisition updates, including a $6.25M REN NSR add-on and new Nevada royalties.